Eva Schrezenmeier

The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling.

Moderate correlations of in vitro versus in vivo pharmacokinetics questioning the need of early microsomal stability testing.

The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein.

Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?

Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany.

Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.

Assessment of the Kidney Donor Profile Index in a European cohort.

Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.

Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations.

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.

Diagnostic Utility of Exome Sequencing for Kidney Disease.

EZH2 Inhibition in B Cell Subsets: Comment on the Article by Rohraff et al.

Mutations Implicate RAB11-Dependent Vesicular Trafficking in the Pathogenesis of Nephrotic Syndrome.

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.

Role for antimalarials in the management of COVID-19.

The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single-center cohort study.

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients.

What happens after graft loss? A large, long-term, single-center observation.

The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation.

Deep Phenotyping of CD11c B Cells in Systemic Autoimmunity and Controls.